Agilent Technologies Research and Development Expenses 2010-2025 | A

Agilent Technologies research and development expenses for the twelve months ending April 30, 2025 were $463M, a 2.11% decline year-over-year.

  • Agilent Technologies annual research and development expenses for 2024 were $0.479B, a 0.42% decline from 2023.
  • Agilent Technologies annual research and development expenses for 2023 were $0.481B, a 3% increase from 2022.
  • Agilent Technologies annual research and development expenses for 2022 were $0.467B, a 5.9% increase from 2021.

Agilent Technologies Research and Development Expenses 2010-2025 | A

  • Agilent Technologies annual research and development expenses for 2024 were $0.479B, a 0.42% decline from 2023.
  • Agilent Technologies annual research and development expenses for 2023 were $0.481B, a 3% increase from 2022.
  • Agilent Technologies annual research and development expenses for 2022 were $0.467B, a 5.9% increase from 2021.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$229.3B
Boston Scientific (BSX)$152.9B
Stryker (SYK)$146B
EssilorLuxottica (ESLOY)$145.1B
Medtronic (MDT)$119.2B
Lonza Group Ag (LZAGY)$48.3B
Haleon (HLN)$43.3B
ResMed (RMD)$41.7B
GE HealthCare Technologies (GEHC)$33.5B
Terumo (TRUMY)$27.6B
Koninklijke Philips (PHG)$26.5B
Insulet (PODD)$22.6B
Zimmer Biomet Holdings (ZBH)$20.4B
Smith & Nephew SNATS (SNN)$15.9B
Baxter (BAX)$12.4B
Sunny Optical Technology (SNPTF)$10.8B
Demant (WILYY)$8.1B
Bio-Rad Laboratories (BIO)$7.7B
Lantheus Holdings (LNTH)$3.7B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
Envista Holdings (NVST)$3.4B
Prestige Consumer Healthcare (PBH)$3.2B
Perrigo (PRGO)$3.1B
ICU Medical (ICUI)$3B
Haemonetics (HAE)$2.6B
LeMaitre Vascular (LMAT)$2.2B
Curaleaf Holdings (CURLF)$1.8B
AtriCure (ATRC)$1.8B
QuidelOrtho (QDEL)$1.8B
Green Thumb Industries (GTBIF)$1.6B